Company Announcements

Director/PDMR Shareholding

Source: RNS
RNS Number : 9526T
Herald Investment Trust PLC
27 July 2022
 

 

 

Herald Investment Trust plc

Director/PDMR Shareholding

 

The Company has been informed that Karl Sternberg, a non-executive director of the Company, today bought 1,000 ordinary shares of 25p nominal value each in the capital of the Company ("Ordinary Shares") at a price of 16.80p per share.

 

Following the above mentioned acquisition, Karl Sternberg is beneficially interested in 9,826 Ordinary Shares.

 

27 July 2022

 

 

Enquiries:

 

Sanne Fund Services (UK) Limited (Company Secretary)

Shilla Pindoria              Tel: +44 (0)20 3327 9720

 

The notification below, made in accordance with the requirements of the Market Abuse Regulation, provide further detail.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Karl Sternberg

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-executive director

b)

 

Initial notification /Amendment

 

Initial

3

 

Details of the issuer

 

a)

 

Name

 

 

Herald Investment Trust plc

b)

 

LEI

 

 

213800U7G1ROCTJYRR70

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 25 pence



Identification code

GB0004228648



b)

 

Nature of the transaction

 

 

Market Purchase

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




£16.80

1,000







d)

 

Aggregated information




- Aggregated volume

1,000



- Price

£16,800.00



e)

 

Date of the transaction

 

27 July 2022

f)

 

Place of the transaction

 

London

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBBGDRUDDDGDR